Skip to main content
Omega Therapeutics, Inc. (OMGA)
NASDAQ: OMGA · IEX Real-Time Price · USD
2.070
-0.180 (-8.00%)
At close: Jul 2, 2024, 4:00 PM
2.140
+0.070 (3.38%)
After-hours: Jul 2, 2024, 7:22 PM EDT

Omega Therapeutics Revenue

Omega Therapeutics had revenue of $4.94M in the twelve months ending March 31, 2024, with 112.70% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $2.36M with 357.36% year-over-year growth. In the year 2023, Omega Therapeutics had annual revenue of $3.09M with 49.25% growth.

Revenue (ttm)
$4.94M
Revenue Growth
+112.70%
P/S Ratio
23.12
Revenue / Employee
$53,108
Employees
93
Market Cap
114.17M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20233.09M1.02M49.25%
Dec 31, 20222.07M1.93M1,339.58%
Dec 31, 2021144.00K--
Dec 31, 20200--
Dec 31, 20190--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

OMGA News

More News